Budget Caps Clause Samples

Budget Caps. Administration - up to 15% of total contracted budget may be used for administration. See Section 4 for details on allowable expenses for Administration and Program Operations.

Budget Caps. Administration - up to 15% of total contracted budget may be used for administration. See Section 4 for details on allowable expenses for Administration and Program Operations. Lead grantees must bill Commerce monthly for reimbursement of allowable costs. Invoices are due on the 20th of the month following the billing period. Final invoices for a biennium may be due sooner than the 20th. If the lead grantee fails to submit an invoice within a three-month period, without a reasonable explanation, Commerce may take corrective action resulting in withholding of payment or reduction in contracted amount. Exceptions to billing procedures can be negotiated with Commerce on a case-by-case basis. Invoices must be submitted online using the Commerce Contract Management System (CMS) via Secure Access Washington (SAW). Contact your Commerce representative for access to the online invoicing system. Requests for reimbursement must be accompanied by the CBRA Monthly Voucher Detail Report attached to the online invoice. Source documentation such as cancelled checks, purchase orders, or time sheets are not required. Commerce may require a lead grantee to submit additional documentation as needed to approve reimbursement. Lead grantees must retain original invoices submitted by their subgrantees. Budget revisions that move more than 10 percent of the grant total require a budget amendment. The Administration budget cap must be maintained with each revision. Grantees must inform Commerce if CBRA funds are spent on ineligible households or expenses. Reasonable attempts must be made to prevent ineligible use of funds.

Budget Caps. ✓ For-Profit Set Aside - At least 36 percent of the non-HEN CHG funds must be budgeted and spent on rent/lease payments to private for-profit entities. • Non-profit, for-profit, and government ownership of properties is determined by the tax status of the entity that owns the property. See Appendix E: Process for Identifying Private, For-profit Landlords. ✓ Administration - up to 15 percent of total non-HEN reimbursed costs may be used for administration. ✓ HEN Administration - up to 7 percent of total HEN reimbursed costs may be used for HEN administration. ✓ TANF Households - the sum of TANF household budget categories must always be equal to the original TANF household allocation. ✓ HEN Households - the sum of HEN household budget categories must always be equal to the original HEN household allocation. Reimbursements Lead grantees must bill Commerce monthly for reimbursement of allowable costs. Invoices are due on the 20th of the month following the provision of services. Final invoices for a biennium may be due sooner than the 20th. If the lead grantee fails to submit an invoice within a three-month period, without a reasonable explanation, Commerce may take corrective action as outlined in the CHG grant Scope of Work. Exceptions to billing procedures can be negotiated with Commerce on a case-by-case basis. Invoices must be submitted online using the Commerce Contract Management System (CMS) through Secure Access Washington (SAW). All submitted invoices must include the CHG Voucher Detail Worksheet (if grantee has subgrantees) and the 2016-2017 Invoice Report. Invoices may not be paid until the report(s) are received and verified. Commerce may require a lead grantee to submit additional documentation. Lead grantees must retain original invoices submitted by their subgrantees. Budget Revisions Revisions must be submitted using the Budget Revision Tool and approved by Commerce. Caps on budget categories (2.3 Fiscal Administration) must be maintained with each revision. An amendment is required when revisions (in one or cumulative transfers) reach more than 10 percent of the grant total.

Budget Caps. (a) Pharming shall have no obligation to pay to Orchard any Orchard Pre-Clinical Research Costs with respect to any activity(ies) under the Pre-Clinical Plan to the extent exceeding [_____] of the Costs allocated to such activity(ies) under the Pre-Clinical Budget, and such excess Costs shall be deemed excluded from Orchard Pre- Clinical Research Costs, unless such excess Costs are thereafter covered by any Pre-Clinical Budget amended by the JSC. (b) Either Party shall have no obligation to share the NTCR Activities Costs incurred by the other Party or its Affiliates with respect to any NTCR Activity(ies) to the extent exceeding [_____] of the Costs allocated to be incurred by such Party for such NTCR Activity(ies) under the NTCR Budget, and such excess Costs shall be deemed excluded from the NTCR Activities Costs, unless such excess Costs are thereafter covered by any NTCR Budget amended by the JSC. (c) If either Party reasonably expects that it will incur, in the case of Orchard, Orchard Pre-Clinical Research Costs or, in the case of either Party, NTCR Activities Costs in excess of the corresponding 50 budgeted Costs in the Pre-Clinical Budget or NTCR Budget (as applicable), then subject to Sections 9.2.1(a) and 9.2.1(b), such Party shall promptly inform the JSC with respect thereto, upon which the JSC shall discuss and, if appropriate, approve any amendment of such Pre-Clinical Budget or NTCR Budget (as applicable) to cover such excess Costs under Section 2.2.8. In the event that the JSC delays, conditions or refuses its consent under Section 2.2.8 to approve any such amendment to cover such excess Costs (above [_____] of the applicable Costs set out in the Pre- Clinical Budget or NTCR Budget), then such Party shall not be liable for any delay or failure to perform its obligations under the Pre-Clinical Plan or its NTCR Activities (as applicable), to the extent caused by such delay or refusal to give consent, provided that such Party shall remain liable for such delay or failure to perform its obligations, if such actual or potential excess Costs are caused by such Party’s failure to perform its obligations under the Pre-Clinical Plan or its NTCR Activities using its Commercially Reasonable Efforts or its failure to materially comply with Applicable Laws.